Optometrists in Bethel, VT Accepting Medicare
5 Optometrists found. Showing 1 - 5
 Dr. Luben Metodiev Ikonomov, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 1593 Vermont Route 107, Bethel, VT 05032 Phone: 802-234-9728 Fax: 802-234-9728 |
 Eyecare For You, Pc Optometrist Medicare: Medicare Enrolled Practice Location: 1593 Vt Rt 107, Bethel, VT 05032 Phone: 802-234-9728 Fax: 802-234-9732 |
Jerry Albert Barcelow Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1593 Vt Rte 107, Bethel, VT 05032 Phone: 802-234-9728 Fax: 802-234-9732 |
Dr. Dean A Barcelow, O.D. Optometrist Medicare: May Accept Medicare Assignments Practice Location: 1593 Vermont Route 107, Bethel, VT 05032 Phone: 802-234-9728 Fax: 802-234-9732 |
 Dr. Rebecca E Barcelow, O.D. Optometrist Medicare: May Accept Medicare Assignments Practice Location: 1593 Vermont Route 107, Bethel, VT 05032 Phone: 802-235-9728 |
News Archive
Class action law suit filed on behalf of children with autism against ELARC
Today, attorneys with Public Counsel and Gibson, Dunn & Crutcher LLP filed a class action law suit and preliminary injunction on behalf of children with autism against the Eastern Los Angeles Regional Center (ELARC) for unlawfully terminating the most effective treatment for their condition.
FDA accepts MAP Pharmaceuticals' resubmission of NDA for LEVADEX
MAP Pharmaceuticals, Inc. today announced that its New Drug Application (NDA) resubmission for LEVADEX orally inhaled migraine drug for the potential acute treatment of migraine in adults has been accepted for filing by the U.S. Food and Drug Administration (FDA).
Navy researchers evaluate commercial UV sources for viral disinfection to combat COVID-19
U.S. Naval Research Laboratory researchers evaluated commercial ultraviolet (UV) sources for viral disinfection to combat COVID-19 on land and at sea, and established a dedicated UV characterization lab in five days to ensure safe introduction and effective operation of UV sources across the Fleet.
First-trimester ultrasound may lead to earlier abortion
Early diagnosis of structural fetal abnormalities by ultrasound during the first trimester would give women the option of undergoing abortion at a safer time in their pregnancy, research indicates.
Cephalon acquires biotechnology company, Ception Therapeutics
Cephalon, Inc. announced today that it has completed its previously announced acquisition of biotechnology company Ception Therapeutics, Inc. and that Ception is now a wholly-owned subsidiary of Cephalon.
› Verified 6 days ago